Marshall Wace’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Marshall Wace’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-86,800	Closed	-$3.66M	–	2830
2023 Q2	$3.66M	Buy	+86,800	New	+$3.51M	0.01%	1154
2022 Q2	–	Sell	-7,714	Closed	-$625K	–	3995
2022 Q1	$625K	Buy	+7,714	New	+$653K	﹤0.01%	2675
2021 Q4	–	Sell	-5,054	Closed	-$442K	–	4417
2021 Q3	$442K	Sell	5,054 -40,678	-89%	-$3.68M	﹤0.01%	2450
2021 Q2	$4.09M	Buy	+45,732	New	+$3.86M	0.02%	959
2021 Q1	–	Sell	-206,031	Closed	-$14M	–	2965
2020 Q4	$14M	Buy	206,031 +134,829	+189%	+$8.41M	0.08%	262
2020 Q3	$3.79M	Buy	+71,202	New	+$4.24M	0.02%	610
2020 Q2	–	Sell	-44,969	Closed	-$1.77M	–	2051
2020 Q1	$1.77M	Sell	44,969 -117,251	-72%	-$6.86M	0.02%	666
2019 Q4	$9.65M	Sell	162,220 -18,927	-10%	-$1.02M	0.07%	329
2019 Q3	$9.64M	Sell	181,147 -47,938	-21%	-$2.46M	0.08%	307
2019 Q2	$11.7M	Buy	229,085 +52,036	+29%	+$2.42M	0.1%	240
2019 Q1	$9.16M	Sell	177,049 -206,567	-54%	-$10M	0.09%	284
2018 Q4	$15.1M	Buy	383,616 +348,260	+985%	+$16.2M	0.15%	160
2018 Q3	$1.82M	Buy	+35,356	New	+$1.73M	0.02%	697
2017 Q1	–	Sell	-967,789	Closed	-$50.9M	–	822
2016 Q4	$50.9M	Sell	967,789 -148,230	-13%	-$7.18M	0.33%	79
2016 Q3	$49.8M	Buy	1,116,019 +350,423	+46%	+$15.2M	0.35%	73
2016 Q2	$29.2M	Buy	765,596 +222,972	+41%	+$9.8M	0.25%	102
2016 Q1	$22.4M	Sell	542,624 -107,222	-16%	-$4.42M	0.22%	122
2015 Q4	$31.5M	Buy	649,846 +403,754	+164%	+$18M	0.3%	93
2015 Q3	$9.84M	Buy	246,092 +33,702	+16%	+$1.47M	0.12%	182
2015 Q2	$8.52M	Buy	+212,390	New	+$7.33M	0.11%	203

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Marshall Wace's SYNH Position: Q3 2023 in Review

Marshall Wace sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 86,800 shares — an estimated $3.66M sold.

Marshall Wace first reported a position in SYNH in Q2 2015 and held it in 20 quarters. The position peaked at $50.9M in Q4 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Marshall Wace reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Marshall Wace sold 86,800 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $3.66M.
Marshall Wace first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 20 quarters.
Marshall Wace's Syneos Health, Inc. Class A Common Stock position peaked at $50.9M in Q4 2016.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.